Insider · CIK 0001298709
Krish S Krishnan
ceopresidentofficerdirectorowner
Files at KRYS (Krystal Biotech, Inc.). First filing Dec 13, 2024, latest Sep 4, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $26M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KRYS: Krystal Biotech, Inc.
KRYSOct 9, 2026 · close 331.61
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Krystal Biotech, Inc. | $9.0M 25,000 shares | -2% | - | |
| 45Moderate | Krystal Biotech, Inc. | $8.9M 50,000 shares | -3% | - | |
| 38Weak | Krystal Biotech, Inc. | $8.2M 50,000 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -520 | $354.54 | $184k | 1,372,023 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -2,029 | $355.57 | $721k | 1,369,994 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -3,297 | $356.37 | $1.2M | 1,366,697 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -3,981 | $357.57 | $1.4M | 1,362,716 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -3,143 | $358.42 | $1.1M | 1,359,573 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -3,357 | $359.39 | $1.2M | 1,356,216 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -2,266 | $360.46 | $817k | 1,353,950 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -1,214 | $361.61 | $439k | 1,352,736 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -2,010 | $362.65 | $729k | 1,350,726 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -573 | $363.34 | $208k | 1,350,153 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -1,358 | $364.48 | $495k | 1,348,795 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -847 | $365.42 | $310k | 1,347,948 | 38 d ago |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -405 | $366.56 | $148k | 1,347,543 | 38 d ago |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -1,100 | $175.83 | $193k | 1,556,956 | Mar 13, 2025 |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -4,944 | $176.80 | $874k | 1,552,012 | Mar 13, 2025 |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -10,931 | $177.62 | $1.9M | 1,541,081 | Mar 13, 2025 |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -6,769 | $178.77 | $1.2M | 1,534,312 | Mar 13, 2025 |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -1,256 | $179.57 | $226k | 1,533,056 | Mar 13, 2025 |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -1,639 | $175.97 | $288k | 1,487,072 | Mar 13, 2025 |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -4,579 | $176.88 | $810k | 1,482,493 | Mar 13, 2025 |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -10,937 | $177.66 | $1.9M | 1,471,556 | Mar 13, 2025 |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -6,514 | $178.76 | $1.2M | 1,465,042 | Mar 13, 2025 |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -1,331 | $179.55 | $239k | 1,463,711 | Mar 13, 2025 |
| Feb 26, 2025 | KRYS Krystal Biotech, Inc. | FTax withholding Common Stock | -4,721 | $176.39 | $833k | 1,532,541 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Common Stock | +12,500 | $0.00 | $0 | 1,545,041 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | FTax withholding Common Stock | -5,786 | $179.25 | $1.0M | 1,539,255 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Common Stock | +8,750 | $0.00 | $0 | 1,548,005 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | FTax withholding Common Stock | -4,050 | $179.25 | $726k | 1,543,955 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Common Stock | +26,250 | $0.00 | $0 | 1,570,205 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | FTax withholding Common Stock | -12,149 | $179.25 | $2.2M | 1,558,056 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Common Stockindirect: By Spouse | +7,500 | $0.00 | $0 | 1,483,382 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | FTax withholding Common Stockindirect: By Spouse | -3,471 | $179.25 | $622k | 1,479,911 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Common Stockindirect: By Spouse | +22,500 | $0.00 | $0 | 1,502,411 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | FTax withholding Common Stockindirect: By Spouse | -10,414 | $179.25 | $1.9M | 1,491,997 | Feb 28, 2025 |
| Feb 26, 2025 | KRYS Krystal Biotech, Inc. | FTax withholding Common Stockindirect: By Spouse | -3,286 | $176.39 | $580k | 1,488,711 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Performance Stock Unitsderivative | -12,500 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Restricted Stock Unitsderivative | -8,750 | $0.00 | $0 | 26,250 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Performance Stock Unitsderivative | -26,250 | $0.00 | $0 | 26,250 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +39,300 | $0.00 | $0 | 39,300 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | AGrant or award Restricted Stock Unitsderivative | +22,900 | $0.00 | $0 | 22,900 | Feb 28, 2025 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -6,302 | $163.07 | $1.0M | 1,555,960 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -8,381 | $163.91 | $1.4M | 1,547,579 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -4,909 | $164.93 | $810k | 1,542,670 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -1,977 | $165.82 | $328k | 1,540,693 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -923 | $166.93 | $154k | 1,539,770 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -911 | $169.65 | $155k | 1,538,859 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -957 | $170.47 | $163k | 1,537,902 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -640 | $171.63 | $110k | 1,537,262 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -5,942 | $163.04 | $969k | 1,494,940 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -8,923 | $163.92 | $1.5M | 1,486,017 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -4,723 | $164.92 | $779k | 1,481,294 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -2,114 | $165.79 | $350k | 1,479,180 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -798 | $166.96 | $133k | 1,478,382 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -200 | $168.31 | $34k | 1,478,182 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -953 | $169.48 | $162k | 1,477,229 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -727 | $170.43 | $124k | 1,476,502 | Dec 13, 2024 |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -620 | $171.62 | $106k | 1,475,882 | Dec 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.